Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis
about
Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinomaLoss of HOP tumour suppressor expression in head and neck squamous cell carcinomaIdentification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray dataMapping and characterization of the amplicon near APOA2 in 1q23 in human sarcomas by FISH and array CGHThe homeobox only protein homeobox (HOPX) and colorectal cancerCharacterization of G3BPs: tissue specific expression, chromosomal localisation and rasGAP(120) binding studies.An oncogenic role for the phosphorylated h-subunit of human translation initiation factor eIF3Recurrent amplification of RTEL1 and ABCA13 and its synergistic effect associated with clinicopathological data of gastric adenocarcinoma.Genomic shotgun array: a procedure linking large-scale DNA sequencing with regional transcript mapping.Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression.Investigation of chromosomal aberrations in Egyptian hepatocellular carcinoma patients by fluorescence in situ hybridization.Transgenic CHD1L expression in mouse induces spontaneous tumors.CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.Gene expression patterns in human liver cancers.Identification of drivers from cancer genome diversity in hepatocellular carcinoma.Digital karyotyping reveals probable target genes at 7q21.3 locus in hepatocellular carcinoma.Overexpression of cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinomaRNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma.Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancerHuman hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1.Increased expression of glycosyl-phosphatidylinositol anchor attachment protein 1 (GPAA1) is associated with gene amplification in hepatocellular carcinoma.Detection of chromosomal imbalances in hepatocellular carcinoma.Genetic mechanisms of hepatocarcinogenesis.A potent modifier of liver cancer risk on distal mouse chromosome 1: linkage analysis and characterization of congenic lines.The prognostic molecular markers in hepatocellular carcinoma.Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention.Assessment of the Proliferative Marker Ki-67 and p53 Protein Expression in HBV- and HCV-related Hepatocellular Carcinoma Cases in Egypt.S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesisChromosomal aberrations related to metastasis of human solid tumorsClinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.The 17q23 amplicon and breast cancer.Overexpression of N-terminal kinase like gene promotes tumorigenicity of hepatocellular carcinoma by regulating cell cycle progression and cell motility.Regulation of DNA repair by S-nitrosylation.Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer.Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcomeHypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma.Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutationDiagnostic impact of fluorescence in situ hybridization in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma.Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma.Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitors
P2860
Q21092852-4F1B13BE-077B-4FDB-9296-2F68EE0B58B9Q24645549-39EC77D9-F83E-43AE-B8ED-2789A1E98291Q24803258-B1A2F806-694B-48ED-85AC-4B4455FF791FQ24815629-5A22D739-FD6D-4B96-BB98-9C26A2FFC22CQ27004699-F6BBFBAE-A80A-489D-801A-0813F83A48B2Q30167725-2D22DC84-36F7-4AFF-ADAC-9F3310DAA197Q30438861-538890FA-E2AD-45B7-87DF-D9410BC0AAD0Q31111741-42172187-57FF-4E17-8D75-C32D41DF664DQ33198232-7873E50D-7FAA-4B3B-920E-6014920A040BQ33278046-17B6F98E-8A27-4E70-9399-B6A6972A3B7FQ33350024-87713E1B-F438-4362-9008-293D3635181DQ33496125-79D31B65-7EFB-4D22-8620-FCD9872CB47AQ33755370-56742B6E-07E7-4613-88C3-2B7ADF154FA1Q33898932-D4EC3A82-2B83-4B77-885C-04AAAD2C3998Q33907993-E623C69D-C222-4910-9C45-A37BB89394DBQ33964528-1C10CDB7-E628-4B22-92DE-493D80A1651CQ34037880-A490651C-D188-4743-B6F7-7AC47CCB54E3Q34063655-D3437F03-3DFD-4936-8D41-9FB1066F135BQ34083417-76C993FE-D4B3-4DAD-B462-834DB1E4E23FQ34136464-B1C5FE4B-D6F5-4098-9C85-05A1B0103480Q34518318-C9B4C317-E5CA-475E-8205-2999D2BCD2A7Q34606310-683B4046-62D0-484A-9878-60D75D53CF04Q34611410-2375E9B5-FF43-41C4-AE14-364FD553D527Q34645162-39AD3BF3-1B48-41ED-BFE5-133440FA9225Q34668320-7DE094E2-35DA-49FB-9F08-EDDD451F8483Q34733981-0A21671F-9012-4D4F-B54E-11D44CD60645Q34747158-EBBB8F97-33DE-4BE5-93BF-FC5ED3C43805Q34904694-D8542DBD-3F78-48FD-A674-1F9BFA368120Q34961715-A5F37E61-BE3B-4E31-849D-D9FE71CA6DDFQ35010949-6B6F5688-666B-45A4-A844-091BF35F298FQ35130683-90D71BBD-AEC6-47EC-951D-B1FA169F086EQ35176391-C2F9E7E9-C626-4ED1-BF76-F20F2D2CA9D8Q35206885-596F4B24-C096-4E29-983B-F58E885A440CQ35491733-B6DEB19A-3730-4095-9AAB-B7D40635E508Q35745691-30CB6420-2EF7-4D47-8261-6CF1CFD3770CQ35746961-3B55A3E8-821A-47D1-8522-46FBBE1BCBDFQ35748034-23E2C5D9-0E7F-4075-B620-D916D589B0DDQ35870353-0558FA5C-E5A2-4595-B6F4-559ED9871E39Q36017905-57C1FC18-0891-4AF0-B058-14FB5213B458Q36129235-20733D0C-01BB-44DB-AC6E-C67F3CABCD8B
P2860
Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Assessment of genetic changes ...... age, tumor size, and cirrhosis
@ast
Assessment of genetic changes ...... age, tumor size, and cirrhosis
@en
type
label
Assessment of genetic changes ...... age, tumor size, and cirrhosis
@ast
Assessment of genetic changes ...... age, tumor size, and cirrhosis
@en
prefLabel
Assessment of genetic changes ...... age, tumor size, and cirrhosis
@ast
Assessment of genetic changes ...... age, tumor size, and cirrhosis
@en
P2093
P2860
P1476
Assessment of genetic changes ...... age, tumor size, and cirrhosis
@en
P2093
P J Johnson
P2860
P356
10.1016/S0002-9440(10)65248-0
P407
P577
1999-01-01T00:00:00Z